<DOC>
	<DOC>NCT02192749</DOC>
	<brief_summary>Allogeneic (not from the subject) human umbilical cord tissue-derived stem cells administered intravenously (IV) in a series of 4 infusions every 3 months over the course of one year is safe and will induce a therapeutic effect in autism patients.</brief_summary>
	<brief_title>Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism</brief_title>
	<detailed_description />
	<mesh_term>Autistic Disorder</mesh_term>
	<criteria>Male or Female Ages 6 to 16 Diagnostic and Statistical Manual of Mental Disorders (DSM IV) diagnosis of autism confirmed by Autism Diagnostic Observation Schedule (ADOS) and/or Autism Diagnostic InterviewRevised (ADIR) No anticipated changes in treatment for the study duration (e.g., diet, nutrients) No additional biomedical treatments started 6 weeks prior to enrollment No changes in dietary management for 3 months prior to enrollment Ambulatory or require minimum support walking, per parent Able to sit still for 5 minutes or longer with a preferred toy item, per parent Adequate vision and hearing for the purposes of test administration, per parent Adequate armhandfinger coordination (i.e., able to point) for learning and cognitive tasks used in outcome measurement, per parent Stable and controlled mental disorder Under the care of a caregiver willing to participate by attending regularly scheduled appointments and completing the necessary measures Normal heavy metals test for lead and mercury levels performed within 30 days of first stem cell infusion Must provide name and specialty of specialist who has made Autism Spectrum Disorder (ASD) diagnosis Adequate financial means to cover $7,200 (US Dollars) plus travel expenses Significant prematurity at birth (less than 32 weeks gestation); or birth weight significantly below normal for gestational age (SGA small for gestational age) mental retardation seizure disorder autoimmune conditions history of head trauma and other neurological or medical conditions Abnormal heavy metals test for lead and mercury performed within 30 days of first stem cell infusion Prior stem cell therapy of any kind</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>autism</keyword>
	<keyword>umbilical cord</keyword>
	<keyword>mesenchymal</keyword>
	<keyword>stem cells</keyword>
</DOC>